Stock Market News & Stocks to Watch from StraightStocks » Medical Device

Small Cap Voice Featured Company: Biomagnetics Diagnostics Corp. (BMGP.PK)

QualityStocks — Thu, 12 Nov 2009 17:13:40 +0000

Biomagnetics Diagnostics Corp. is an advanced medical device and biotechnology company with a revolutionary diagnostics system and test kit testing technology for HIV, Hepatitis, H-Pylori, HPV, Tuberculosis and many other viruses, bacterium’s, toxins and diseases. The company focuses on real-time testing for the actual presence of the virus/ toxin/ disease itself, instead of the antibodies [...]

Company News for October 12, 2009 – Corporate Summary

Zacks Market Commentaries — Mon, 12 Oct 2009 14:00:15 +0000

• Blackstone (NYSE:BX) announced plans to list up to eight Blackstone-owned firms and sell at least five additional companies

• Barclays (NYSE:BCS) reported plans to spin off a $6.35 billion portfolio of complex credit assets as it seeks to clean up its balance sheet

• Phillips Electronics (NYSE:PHG) reported better-than-expected third quarter earnings, helped by cost-cutting measures, although the company said most markets are yet to see recovery

• Deutsche Bank (NYSE:DB) lifted Johnson & Johnson's (NYSE:JNJ) price target to $67 from $63 and maintained its "buy" rating on the stock, as the analyst noted "Ahead of Tuesdays earnings call we are raising our price target to $67 (prior $63) based on improving comparable multiples, new product approvals, stabilization in the global economy, and FX tailwinds all [of] which should add to earnings in 4Q and next year. We expect management will focus on continued healthy trends in its Medical Device & Diagnostic division, which will be the highlight of Tuesday's earnings meeting"

• Goldman Sachs' (NYSE:GS) removed Johnson Controls (NYSE:JCI) from its Conviction Sell list in anticipation of optimism after its October 13 analyst day. Goldman raised its price target on the firm to $20 from $18

Zacks Investment Research

How to Find Great Stocks During a Boom or Doom Period

Contrarian Profits — Thu, 04 Jun 2009 20:29:28 +0000

pThis weekend, I’ll be speaking at the ema href="http://mtvernonresearch.com" class="alinks_links"Mt. Vernon Research/a/a href="http://www.investorsdailyedge.com" class="alinks_links"Investor’s Daily Edge/a/em “Boom #38; Doom” conference in South Florida. During my presentations, I’ll offer the attendees my top five stocks that I believe will fare well, no matter whether we’re in a depression or expansion. Now, it wouldn’t be fair to the paying customers if I give you those top five stocks here. But what I can do is provide you with the stockpicking method to my (some say considerable) madness…strong/strong/p pstrongA Fat Pipeline… And An Even Fatter Dividend/strong/p pSeveral of the stocks are in the healthcare sector - my specialized area of expertise./p pNot only do I cover that sector for emMt. Vernon Research,/em I also believe that owning the right healthcare stocks is#8230;/p

Healthcare Stocks Close to the Heart

Bullish Bankers — Sun, 03 May 2009 11:00:22 +0000

With stocks having been beaten down so badly these past few quarters, investors are getting tired of losing money. However, for those of us who are not about to retire, we have to allow some room for patience in our investing strategies. Investing in a company whose stock price appreciates year-over-year is optimal, [...]

Beacon Equity Research Calls Zila, Inc. (ZILA) an “Absolute Bargain Right Now”

QualityStocks — Thu, 05 Feb 2009 15:14:06 +0000

Zila, Inc. (ZILA) is dedicated to the prevention, detection and treatment of oral cancer and other periodontal diseases. The company’s flagship product, ViziLite Plus, is designed for the early detection of oral abnormalities that often lead to cancer. It is recognized as the first and only medical device that has been cleared by the FDA [...]

SurModics, Inc. (SRDX) Responds to Merck’s Termination of License and Research Collaboration

QualityStocks — Fri, 19 Sep 2008 12:32:09 +0000

SurModics, Inc. (NASD: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, recently announced that Merck & Co., Inc. has notified the company that it will discontinue the License and Research Collaboration Agreement the companies signed in June 2007. Shares of SurModics declined sharply earlier this week after the [...]

OmniComm Systems, Inc. (OMCM.OB) Has Another Record Breaking Quarter

QualityStocks — Mon, 07 Jul 2008 20:33:40 +0000

For the third straight quarter in a row, OmniComm Systems, a leader in integrated electronic data capture solutions for clinical trials, is reporting another landmark quarter for new business. The company has surpassed its previous best quarter and signed contracts through the first two quarters of 2008 totaling almost $12 million, which surpass all of [...]